ACO ame and Location Space Coast ACO LLC Previous ames: /A 3535 Little Rd Trinity, FL 34655 ACO Primary Contact Primary Contact ame Jayadeva Chowdappa, MD Primary Contact Phone umber 727-474-9030 Primary Contact Email Address jchowdappa@nhs-aco.com Organizational Information ACO participants: ACO s ACO in Joint Venture (Enter Y or ) Raquel Rodriguez MD PA Medic Solutions LLC Vinaya Kumar PA Caroliese Schmidt MD PA Carlos A Vizcarra MD PA Healthy Journeys Inc Raheel Ahmed MD PA Indian River Internal Medicine LLC Milarn Corporation Two Rivers Family Practice PLLC Brevard Internal Medicine & Walk-In Clinic Ashok Shah MD PA Humayun Shareef MD PA Imran Malik MD LLC Tuya PA Liaquddin Shaikh, MD Radha Medical PA Shreeji Medical PA
Francis A Ashie MD PA Edgar R Blecker MD PA Merit Medical Care LLC ACO governing body: Member Last ame First ame Title/Position Member's Voting Power Expressed as a percentage or number Membership Type ACO Legal Business ame/dba, if Applicable Chowdappa Jayadeva Physician 15% Chairman Delvadia Rasiklal Physician 25% ACO Capraro Frances Physician 25% ACO Morel Guillermo Physician 25% ACO D Andrea Geraldine 10% Medicare Beneficiary Representative Shreeji Medical, PA Two Rivers Family Practice, PLLC Tuya, PA Key ACO Clinical and Administrative Leadership: Jayadeva Chowdappa ACO Executive Jayadeva Chowdappa Medical Director Gail Moran Jonathan Hofeling Compliance Officer Quality Assurance/Improvement Officer Associated committees and committee leadership: Committee ame Committee Leader ame and Position Quality Improvement (QI) Edgar Blecker, MD - Chair Guilllermo Morel, MD Caroliese Schmidt, MD Jeram Chapla, MD Utilization Review Guillermo Morel, MD Chair Carlos Vizcarra, MD Edgar Blecker, MD
Types of ACO participants, or combinations of participants, that formed the ACO: etworks of individual practices of ACO professionals Shared Savings and Losses Amount of Shared Savings/Losses First Agreement Period o Performance Year 2017, $2,613,939 o Performance Year 2016, $1,668,857 Shared Savings Distribution First Agreement Period o Performance Year 2017 Proportion invested in infrastructure: 14% Proportion invested in redesigned care processes/resources: 33% Proportion of distribution to ACO participants: 53% o Performance Year 2016 Proportion invested in infrastructure: 23% Proportion invested in redesigned care processes/resources: 6% Proportion of distribution to ACO participants: 71% Quality Performance Results 2017 Quality Performance Results: ACO# Measure ame Rate ACO Mean 1 CAHPS: Getting Timely Care, Appointments, and Information 78.77 80.60 2 CAHPS: How Well Your Providers Communicate 91.71 93.13 3 CAHPS: Patients Rating of Provider 91.53 92.31 4 CAHPS: Access to Specialists 85.10 83.32 5 CAHPS: Health Promotion and Education 63.00 62.30 6 CAHPS: Shared Decision Making 75.87 75.85 7 CAHPS: Health Status/Functional Status 71.48 73.05
34 CAHPS: Stewardship of Patient Resources 24.24 25.68 8 Risk Standardized, All Condition Readmission 15.10 15.01 35 36 37 Skilled ursing Facility 30-day All-Cause Readmission measure (SFRM) 19.43 18.46 All-Cause Unplanned Admissions for Patients with Diabetes 56.55 53.95 All-Cause Unplanned Admissions for Patients with Heart Failure 65.96 79.16 38 43 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 55.01 61.74 1.83 1.93 11 12 13 44 14 15 Use of Certified EHR Technology 100.00 98.48 Medication Reconciliation 98.82 75.32 Falls: Screening for Future Fall Risk 77.04 74.38 Imaging Studies for Low Back Pain 68.29 67.32 Preventive Care and Screening: Influenza Immunization 53.75 72.52 Pneumonia Vaccination Status for Older Adults 46.74 72.92 16 17 18 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 89.23 70.69 96.25 90.48 60.71 61.98 19 20 Colorectal Cancer Screening 63.42 64.58 Breast Cancer Screening 63.06 70.05 42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 76.79 79.89 27 41 Diabetes Mellitus: Hemoglobin A1c Poor Control 16.27 16.74 Diabetes: Eye Exam 41.02 50.37
28 30 Hypertension (HT): Controlling High Blood Pressure 73.42 71.47 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 78.25 86.86 Please note, the 40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples. For 2017 Quality Performance Results please visit: https://data.cms.gov/special-programs- Initiatives-Medicare-Shared-Savin/2017-Shared-Savings-Program-SSP-Accountable-Care- O/gk7c-vejx/data For 2016 Quality Performance Results please visit: https://data.cms.gov/special-programs- Initiatives-Medicare-Shared-Savin/2016-Shared-Savings-Program-SSP-Accountable-Care- O/3jk5-q6dr/data ote: In the Quality Performance Results file(s) above, search for Space Coast ACO LLC or Space Coast ACO to view the quality performance results. This ACO can also be found by using the ACO ID A61540 in the public use files on data.cms.gov. Payment Rule Waivers o, our ACO does not use the SF 3-Day Rule Waiver.